ArticleFrontiers in public health2021

Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis.

Zhuolin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.